US Patent 6869593 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

Patent 6869593 was granted and assigned to Beth Israel Deaconess Medical Center on March, 2005 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Beth Israel Deaconess Medical Center

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

68695930

Patent Inventor Names

John V. Frangioni0

Date of Patent

March 22, 2005

Patent Application Number

104245720

Date Filed

April 25, 2003

Patent Citations Received

‌

US Patent 12110283 Carbonic anhydrase targeting agents and methods of using same

Patent Primary Examiner

‌

Fiona T. Powers

Patent abstract

The present invention is directed to a non-isotopic methods for the in vitro and in vivo detection of hydroxyapatite-positive cells and structures.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6869593 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API